Sponsor Information
CIPLA AUSTRALIA PTY LTD
Active Ingredients
Adalimumab
374373
CIPTUNEC adalimumab 40 mg/0.4 mL solution for subcutaneous injection pre-filled pen
Cipla Australia Pty Ltd
September 6, 2022
Medicine
Medicine
Registered
CIPLA AUSTRALIA PTY LTD
Adalimumab
Empowering clinical research with data-driven insights and AI-powered tools.
© 2025 MedPath, Inc. All rights reserved.